极深 发表于 2025-3-28 17:09:42

http://reply.papertrans.cn/59/5869/586868/586868_41.png

Impugn 发表于 2025-3-28 18:59:23

http://reply.papertrans.cn/59/5869/586868/586868_42.png

mechanism 发表于 2025-3-29 01:46:52

The St Thomas’ Atherosclerosis Regression Study and an appraisal of its potential limitationsoint blinded study of the effects of lipid-lowering therapy on angiographic coronary artery disease (CAD) in male patients with hypercholesterolemia. Both a fat-modified diet and diet-plus cholestyramine favourably influenced the course of CAD over 3 years. As discussed in this paper, the study did,

诗集 发表于 2025-3-29 03:08:16

http://reply.papertrans.cn/59/5869/586868/586868_44.png

MAL 发表于 2025-3-29 09:25:01

http://reply.papertrans.cn/59/5869/586868/586868_45.png

终点 发表于 2025-3-29 11:54:39

Impact upon angiographic disease progression following step drug therapy in normolipidaemic patients potential benefit of drug therapy in normocholesterolaemic patients has not been examined in a randomized prospective fashion. Patients with symptomatic coronary artery disease with at least one lesion narrowed by >30% were randomized to either placebo (. = 39), or stepped drug therapy using pravas

happiness 发表于 2025-3-29 17:17:56

L. Campeau,J. Lespérance,D. Waters,CCAIT Investigators

捕鲸鱼叉 发表于 2025-3-29 19:52:51

http://reply.papertrans.cn/59/5869/586868/586868_48.png

MOTIF 发表于 2025-3-30 01:49:58

http://reply.papertrans.cn/59/5869/586868/586868_49.png

Cleave 发表于 2025-3-30 04:24:37

http://reply.papertrans.cn/59/5869/586868/586868_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis; Albert V. G. Bruschke,Johan H. C. Reiber,Hein J. J Book 1996 Kluwer Ac